登录查看更多内容

RETT SYNDROME RESEARCH, TOWARDS THE FUTURE

Alessio Cortelazzo

Clinical Trial Manager | Director Diagnostic | Associate Professor in Clinical Biochemistry and Clinical Molecular Biology

发布日期: 2018年10月7日

+ 关注

"Brain protein changes in Mecp2 mouse mutant models:

effects on disease progression of Mecp2 brain specific gene reactivation"

Alessio Cortelazzo

Azienda Ospedaliera Universitaria

Senese (Italy)

要查看或添加评论，请登录

Alessio Cortelazzo的更多文章

A revision of the ICH Common Technical Document (CTD)

2023年3月13日

A revision of the ICH Common Technical Document (CTD)

A revision of the ICH Common Technical Document expected this year will set the global stage for eventual “structured”…
Medical devices, point-of care-testing and biosensors: healthcare industry insights from the Council of the European Union

2023年3月7日

Medical devices, point-of care-testing and biosensors: healthcare industry insights from the Council of the European Union

Market is estimated to grow on average at a 10% beetween 2023 and 2033 towards a personalized medicine and a…

1 条评论
The Magic Velvet Bean ... the most read research item

2019年9月3日

The Magic Velvet Bean ... the most read research item
Risposta infiammatoria "attenuata" nella sindrome CDKL5: un approccio proteomico.

2018年10月26日

Risposta infiammatoria "attenuata" nella sindrome CDKL5: un approccio proteomico.

Alessio Cortelazzo Associazione per favorire la ricerca della cura sul cdkl5 Referenza: Cortelazzo A, et al…
Emerging Role of Mass Spectrometry on Clinical Setting: Critical Issues and Perspectives

2018年6月1日

Emerging Role of Mass Spectrometry on Clinical Setting: Critical Issues and Perspectives

Mini Review - Volume 7 Issue 1 - May 2018 Before Mass Spectrometry Finds Application in the Real Clinical Setting…
THE 33RD WORLD CONGRESS OF BIOMEDICAL LABORATORY SCIENCE (IFBLS)

2018年5月12日

THE 33RD WORLD CONGRESS OF BIOMEDICAL LABORATORY SCIENCE (IFBLS)

2018 [22-26 SEPTEMBER] PALAZZO DEI CONGRESSI [ITALY FIRENZE] LABS BEYOND WALLS - SUNDAY 23 SEPTEMBER A. Bonari - A.
Laboratory and diagnostic test mobile systems: critical issues and perspectives in the field of major disasters

2018年3月23日

Laboratory and diagnostic test mobile systems: critical issues and perspectives in the field of major disasters

Biomedicine and Prevention Citation: Mattaccini S, Cortelazzo A , Foglietta G, Transerici M, Coltellaro A, Gemmellaro…
I'm sharing a very interesting paper titled "The ItRC Volunteer Military Corps: Role of Civil Protection and Civil Defense in CBRN Emergencies"

2018年3月23日

I'm sharing a very interesting paper titled "The ItRC Volunteer Military Corps: Role of Civil Protection and Civil Defense in CBRN Emergencies"

Role of Civil Protection and Civil Defense in CBRN Emergencies Citation: Lupini G, Tripodi R and Rossetti P - The ItRC…
Contrasting aspects of snake venom toxins: deadly to humans and useful for the development of diagnostic tests

2018年3月6日

Contrasting aspects of snake venom toxins: deadly to humans and useful for the development of diagnostic tests

Cortelazzo Alessio The first studies on snake venom date back to 1700 and were made by the Italian scientist Felice…
"Biosafety First" La diagnostica di laboratorio per lo studio dei microrganismi ad alta diffusibilità

2018年2月19日

"Biosafety First" La diagnostica di laboratorio per lo studio dei microrganismi ad alta diffusibilità

Alessio Cortelazzo The International Federation of Biomedical Laboratory Science (IFBLS)https://www.ifbls.

See all articles

RETT SYNDROME RESEARCH, TOWARDS THE FUTURE

Alessio Cortelazzo

Clinical Trial Manager | Director Diagnostic | Associate Professor in Clinical Biochemistry and Clinical Molecular Biology

Alessio Cortelazzo的更多文章

社区洞察

其他会员也浏览了

Gene therapy with HSCs stabilizes factor VIII in hemophilia A

How to deliver your target Oligonucleotide into cells?

Prediction of Metabolic Profiles from Transcriptomics Data in Human Cancer Cell Lines

A Cat who Curates Rare Mice

Using Gene Therapies to Treat Chronic, Inflammatory Conditions

Delivering Oligonucleotide Therapies to Any Cell Type

Shifting Cell and Gene Therapy Discourse

FDA Approved Cell & Gene Therapies

Specifying cellular context of transcription factor regulons for exploring context-specific gene regulation programs

Recent Research Advances of Fabry Disease - Gene therapy

Alessio Cortelazzo的更多文章

A revision of the ICH Common Technical Document (CTD)

Medical devices, point-of care-testing and biosensors: healthcare industry insights from the Council of the European Union

The Magic Velvet Bean ... the most read research item

Risposta infiammatoria "attenuata" nella sindrome CDKL5: un approccio proteomico.

Emerging Role of Mass Spectrometry on Clinical Setting: Critical Issues and Perspectives

THE 33RD WORLD CONGRESS OF BIOMEDICAL LABORATORY SCIENCE (IFBLS)

Laboratory and diagnostic test mobile systems: critical issues and perspectives in the field of major disasters

I'm sharing a very interesting paper titled "The ItRC Volunteer Military Corps: Role of Civil Protection and Civil Defense in CBRN Emergencies"

Contrasting aspects of snake venom toxins: deadly to humans and useful for the development of diagnostic tests

"Biosafety First" La diagnostica di laboratorio per lo studio dei microrganismi ad alta diffusibilità

社区洞察

其他会员也浏览了

Gene therapy with HSCs stabilizes factor VIII in hemophilia A

How to deliver your target Oligonucleotide into cells?

Prediction of Metabolic Profiles from Transcriptomics Data in Human Cancer Cell Lines

A Cat who Curates Rare Mice

Using Gene Therapies to Treat Chronic, Inflammatory Conditions

Delivering Oligonucleotide Therapies to Any Cell Type

Shifting Cell and Gene Therapy Discourse

FDA Approved Cell & Gene Therapies

Specifying cellular context of transcription factor regulons for exploring context-specific gene regulation programs

Recent Research Advances of Fabry Disease - Gene therapy